"MMC has granted 4 credit points"
Centre for Cancer Epidemiology (CCE) is the new centre established by Tata Memorial Centre, Mumbai, one of the premier tertiary cancer treatment and research centres in South Asia. The CCE is built on around 60,000 sq feet area with facilities for data storage, high speed servers, high throughput technologies and cold storage of biological samples including automated biobanks for storage of 3 million biological samples. The CCE has the following major goals:
Build a program to identify cancer burden, cancer causation and cancer prevention strategies
Build a platform to conduct large scale cutting-edge epidemiological studies with precise exposure assessment
Partner with universities and other organizations within India and internationally to foster leading edge collaborative science
It gives us great pleasure to invite you to
“Scientific Symposium: Frontiers in Epidemiology” to commemorate the inaugural function for CCE. This progress towards building a dedicated centre for Cancer Epidemiology, a first in India and one of the few globally, is important given the increasing burden of cancer in India and South East Asian countries, with populations that have heterogeneous lifestyles and diverse genetic ancestries.
This scientific symposium will feature a galaxy of scientists speaking upon various topics ranging from cancer burden, risk factors, population genetics, biomarker assessment, and their role in prevention.
Sir Richard Peto, leading epidemiologist and statistician will deliver the prestigious conference oration. Dr. Chris Wild, Director IARC; Dr. Soumya Swaminathan, Director, ICMR, and more than 25 others key world scientific leaders will deliberate their views on the current status and future directions in cancer research over two days of the symposium on carefully chosen themes in the form of lectures and debate. We are sure that the symposium will be an academic feast and would appeal to all scientists, clinicians and health care professional involved in the research and treatment of cancer.
We encourage participants to register and present their work in the form of posters. The US-NCI is partnering with us to organize this symposium. We look forward to seeing you in large numbers.
Dr. R. Badwe Dr. Rajesh Dikshit
Director TMC Prof. & Incharge CCE